Skip to content
DraconiticResearch
Search Sources API
178,033 studies31 sourcesUpdated 15 min ago
Peer-reviewedLicence not statedImmunotherapy

Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling

8 affiliations
  1. 1Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
  2. 2Department of Urology, Institute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
  3. 3Department of Gastrointestinal Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai, China
  4. 4School of Cultural Heritage and Information Management, Shanghai University, Shanghai, China
  5. 5School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
  6. 6School of Clinical Medicine, Anhui Medical University, Hefei, China
  7. 7National Key Laboratory of Immunity and Inflammation, The First Affiliated Hospital of Naval Medical University/Changhai Hospital, Naval Medical University, Shanghai, China
  8. 8Changhai Clinical Research Unit, The First Affiliated Hospital of Naval Medical University/Changhai Hospital, Naval Medical University, Shanghai, China

Related

  1. Early Assessment of Circulating Tumor Cells and Their PD-L1 Expression as Predictive Biomarkers in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: An Exploratory Study
    Emmanuel Grolleau, David Barthelemy, Aurélien Millet +10
    ImmunoTargets and TherapyPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  2. Correlation between circulating tumor cell levels and tumor response in patients with advanced hepatocellular carcinoma undergoing immunotherapy and molecular targeted therapy
    Jiangmin Zhou, Huifang Xiong, Honghao Zhou +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Strategies of mechanical adaptations of circulating tumor cells and properties of their cellular microenvironment have predictive and prognostic biomarker value
    M. Gaczynska, F. Ataei, C.-W. Chou +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. Engineering an arginine-nitric oxide circuit in Escherichia coli Nissle 1917 to remodel the tumor microenvironment for enhanced immunotherapy: a review
    Sujuan Li, Yuanhang Zhang, Pengfei Sun
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Targeting the Tumor Microenvironment Network to Overcome Immunotherapy Resistance in Non‐Small Cell Lung Cancer: Mechanisms to Clinical Translation
    Zengrui Wang, Zhuang Luo, Le Wang +3
    Cancer medicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{liu2026circulating,
  title = {{Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling}},
  author = {Sha Liu and Junjun Lu and Zhaojie Lyu and Zhengmao Lu and Yunmei Liu and Ruiying Zhang and Wentao Xu and Guoping Sun and Yingying Du and Lei Huang},
  journal = {Immunotherapy},
  year = {2026},
  month = oct,
  doi = {10.1080/1750743x.2026.2744059},
  url = {https://doi.org/10.1080/1750743x.2026.2744059},
}
RIS
TY  - JOUR
TI  - Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling
AU  - Sha Liu
AU  - Junjun Lu
AU  - Zhaojie Lyu
AU  - Zhengmao Lu
AU  - Yunmei Liu
AU  - Ruiying Zhang
AU  - Wentao Xu
AU  - Guoping Sun
AU  - Yingying Du
AU  - Lei Huang
PY  - 2026
DA  - 2026/10/09
JO  - Immunotherapy
DO  - 10.1080/1750743x.2026.2744059
UR  - https://doi.org/10.1080/1750743x.2026.2744059
SN  - 1750-743X
SN  - 1750-7448
ER  -